TY - JOUR AU - Zhou, Yijiang AU - Wang, Yanwei AU - Wu, Yutao AU - Huang, Chaoyang AU - Yan, Hui AU - Zhu, Weiguo AU - Xu, Weiwei AU - Zhang, Li AU - Zhu, Jianhua PY - 2017 DA - 2017/06/15 TI - Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials JO - BMC Cardiovascular Disorders SP - 157 VL - 17 IS - 1 AB - High on-treatment platelet reactivity (HPR) represents a strong risk factor for thrombotic events after PCI. We aim to evaluate the efficacy and safety of individualizing intensified dual antiplatelet therapy (DAPT) in PCI-treated patients with HPR based on platelet function testing (PFT). SN - 1471-2261 UR - https://doi.org/10.1186/s12872-017-0582-6 DO - 10.1186/s12872-017-0582-6 ID - Zhou2017 ER -